[The current therapeutic bases for hemophilia].
Négrier
C
C
Centre régional de traitement de l'hémophilie, Inserm U331, hôpital Edouard-Herriot, Lyon, France.
D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D005164:Factor IX / Q000235:genetics / Q000302:isolation & purification / Q000627:therapeutic use; D005169:Factor VIII / Q000235:genetics / Q000302:isolation & purification / Q000627:therapeutic use; D005260:Female; D006467:Hemophilia A / Q000628:therapy*; D002836:Hemophilia B / Q000628:therapy*; D006801:Humans; D008297:Male; D008647:Mesocricetus; D011994:Recombinant Proteins / Q000302:isolation & purification / Q000627:therapeutic use; D012449:Safety; D014766:Viremia / Q000517:prevention & control / Q000635:transmission
D011994:Recombinant Proteins; D005169:Factor VIII; D005164:Factor IX